Adia Nutrition Announces Major Share Structure Overhaul with Retirement of Approximately 15 Million Shares and Cancellation of 10 Million Share Commitment
Adia Nutrition (OTC: ADIA) has announced a significant share structure overhaul, featuring two key developments: the retirement of approximately 15.5 million shares, reducing outstanding common stock from 95.9 million to 80.4 million shares, and the cancellation of a commitment agreement for 10 million additional shares. The retired shares were identified during a review of shares issued without proper documentation. The company is conducting a comprehensive review of share issuance records and plans to file for additional share cancellations if documentation inadequacies are found. CEO Larry Powalisz emphasized the company's commitment to building a transparent capital structure and protecting shareholder interests.
Adia Nutrition (OTC: ADIA) ha annunciato una significativa ristrutturazione della struttura azionaria, con due sviluppi principali: il ritiro di circa 15,5 milioni di azioni, che riduce il numero di azioni ordinarie in circolazione da 95,9 milioni a 80,4 milioni, e la cancellazione di un accordo di impegno per 10 milioni di azioni aggiuntive. Le azioni ritirate sono state individuate durante una revisione delle azioni emesse senza la documentazione adeguata. L'azienda sta conducendo un'analisi approfondita dei registri di emissione azionaria e prevede di richiedere ulteriori cancellazioni di azioni qualora vengano riscontrate altre carenze documentali. Il CEO Larry Powalisz ha sottolineato l'impegno della società a costruire una struttura di capitale trasparente e a tutelare gli interessi degli azionisti.
Adia Nutrition (OTC: ADIA) ha anunciado una importante reestructuración de su estructura accionaria, con dos desarrollos clave: la retirada de aproximadamente 15,5 millones de acciones, reduciendo las acciones comunes en circulación de 95,9 millones a 80,4 millones, y la cancelación de un acuerdo de compromiso para 10 millones de acciones adicionales. Las acciones retiradas fueron identificadas durante una revisión de acciones emitidas sin la documentación adecuada. La compañía está realizando una revisión exhaustiva de los registros de emisión de acciones y planea solicitar cancelaciones adicionales si se encuentran deficiencias documentales. El CEO Larry Powalisz destacó el compromiso de la empresa con construir una estructura de capital transparente y proteger los intereses de los accionistas.
Adia Nutrition (OTC: ADIA)는 주식 구조를 대대적으로 개편한다고 발표했으며, 두 가지 주요 내용이 포함되어 있습니다: 약 1,550만 주의 주식을 소각하여 발행 주식 수를 9,590만 주에서 8,040만 주로 줄이고, 추가 1,000만 주에 대한 약정 계약을 취소하는 것입니다. 소각된 주식은 적절한 문서 없이 발행된 주식을 검토하는 과정에서 확인되었습니다. 회사는 주식 발행 기록을 철저히 검토 중이며, 문서 미비가 발견될 경우 추가 소각 신청을 할 계획입니다. CEO인 래리 포왈리시(Larry Powalisz)는 투명한 자본 구조 구축과 주주 이익 보호에 대한 회사의 의지를 강조했습니다.
Adia Nutrition (OTC : ADIA) a annoncé une révision importante de sa structure actionnariale, comprenant deux développements clés : le retrait d'environ 15,5 millions d'actions, réduisant le nombre d'actions ordinaires en circulation de 95,9 millions à 80,4 millions, ainsi que l'annulation d'un accord d'engagement pour 10 millions d'actions supplémentaires. Les actions retirées ont été identifiées lors d'un examen des actions émises sans documentation appropriée. La société mène une revue approfondie des registres d'émission d'actions et prévoit de déposer des demandes d'annulation supplémentaires si des insuffisances documentaires sont découvertes. Le PDG Larry Powalisz a souligné l'engagement de l'entreprise à construire une structure de capital transparente et à protéger les intérêts des actionnaires.
Adia Nutrition (OTC: ADIA) hat eine bedeutende Umstrukturierung der Aktienstruktur angekündigt, die zwei wesentliche Entwicklungen umfasst: den Rückkauf von etwa 15,5 Millionen Aktien, wodurch die ausstehenden Stammaktien von 95,9 Millionen auf 80,4 Millionen reduziert werden, sowie die Aufhebung einer Verpflichtungsvereinbarung über 10 Millionen zusätzliche Aktien. Die zurückgekauften Aktien wurden bei einer Überprüfung von Aktien ohne ordnungsgemäße Dokumentation festgestellt. Das Unternehmen führt eine umfassende Prüfung der Aktienausgabedokumente durch und plant, bei weiteren Dokumentationsmängeln zusätzliche Aktienrückkäufe zu beantragen. CEO Larry Powalisz betonte das Engagement des Unternehmens, eine transparente Kapitalstruktur aufzubauen und die Interessen der Aktionäre zu schützen.
- Reduction of 15.5 million outstanding shares, decreasing dilution for current shareholders
- Cancellation of 10 million share commitment agreement, preventing future dilution
- Proactive approach to addressing shares issued without proper documentation
- Enhanced transparency through updated share structure reporting on OTC Markets
- Discovery of shares previously issued without proper documentation raises governance concerns
- Potential for additional share cancellations indicates possible further documentation issues
- Company trading on OTC Pink markets, suggesting lower tier listing status
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA), a Winter Park, Florida-based innovator in health and wellness, is excited to announce a transformative overhaul of its share structure, including the retirement of approximately 15 million shares, reducing the outstanding common stock from 95,899,861 to 80,404,696 shares, and the cancellation of a commitment agreement requiring the issuance of 10 million additional shares. These changes are now officially reflected in the company's security details on OTC Markets, underscoring Adia Nutrition's dedication to transparency and maximizing shareholder value.
Share Structure Before Cancellation
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/250803_adiabefore.jpg
The retirement of 15,495,165 shares, combined with the cancellation of the 10 million share commitment, represents a significant milestone in optimizing Adia Nutrition's capital structure. The retired shares were identified as part of a strategic initiative to address shares issued without proper documentation, an issue previously noted in the company's efforts to ensure compliance and integrity. The cancellation of the commitment agreement further reduces potential dilution, reinforcing Adia's commitment to a lean and accurate share count. These actions set a strong precedent for the company's ongoing efforts to retire or cancel any additional shares that do not meet rigorous documentation standards.
Share Structure After Cancellation
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/250803_adiaafter.jpg
"We are focused on building a robust and transparent capital structure that reflects the true value of Adia Nutrition," said Larry Powalisz, Chief Executive Officer of Adia Nutrition. "This milestone highlights our proactive approach to corporate governance and our unwavering commitment to protecting the interests of our shareholders as we drive growth in the health and wellness sector."
With the successful retirement and cancellation of these shares, Adia Nutrition is now prepared to file for the cancellation of additional shares that have been identified as lacking proper documentation. The company has initiated a comprehensive review of its share issuance records to ensure all remaining shares comply with regulatory and corporate governance standards. This ongoing process aims to further enhance the accuracy of the company's outstanding share count and solidify its position as a leader in the health and wellness sector. Any future cancellations or reductions will be promptly reported and updated on OTC Markets, ensuring full transparency with investors.
The updated share structure, reflecting the new outstanding share count of 80,404,696, is now available for review on Adia Nutrition's security details page on OTC Markets (www.otcmarkets.com/stock/ADIA/overview). The company encourages shareholders and prospective investors to visit the site for the most current information.
For questions, inquiries or further information, please contact Larry Powalisz at ceo@adiamed.com or 321-788-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. (OTC Pink: ADIA) is a publicly traded company dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Website: www.adiamed.com
Website: www.adialabs.com
Website: www.biolete.com
Website: www.cementfactory.co
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250803